Oxidative Damage in Red Blood Cells MOA Animation
Working closely with the Hemanext team, we crafted medical animations to elucidate the science behind oxidative damage in stored blood. To leverage the visuals for multiple communication needs, the content was broken into chapters.
What Happens in Blood Cancer?
Blood-Brain Barrier
This editorial image was created for Roche’s pRED to describe their Brain Shuttle technology. The illustration describes the maze-like challenges of delivering an antibody therapeutic across the blood-brain barrier. View our “Brain Shuttle” animation to learn more about the blood-brain barrier and the mechanism of action of Roche’s novel Roche Brain shuttle engineering platform.
Introducing Our New Showreel
We’re excited to unveil our latest showreel, a visual journey through the therapeutic areas and scientific stories that have shaped our recent work. In just two minutes, this reel captures recent years of collaboration, storytelling, and discovery in some of the most dynamic fields of medical science. From oncology and mRNA science to hematology, neurology, …
SONNET PLATFORM MOA ANIMATION
Sonnet BioTherapeutics requested an animation to help explain how their Fully Human Albumin Binding (FHAB) platform functions and the potential benefits of the platform over existing anti-tumor therapies. With vivid colors and key lighting details, the FHAB is clearly the star of the show in this animation.
XOLREMDI WHIM Syndrome MOA Animation
X4 Pharmaceuticals wanted to create a 3D medical animation for the launch of their therapeutic XOLREMDI, indicated for the treatment of WHIM syndrome, a rare immunodeficiency disorder. The main goal was to communicate the complexity of WHIM syndrome and how XOLREMDI cuts through this complexity by targeting the underlying cause of the disease.
SL-172154 MOA Animation
Shattuck Labs enlisted XVIVO to develop a mechanism of action animation for their ARC platform (or Agonist Redirected Checkpoint), which links checkpoint blockade and immune co-stimulation in a single molecule, to treat cancer.
Werewolf Therapeutics PREDATOR platform
XVIVO recently partnered with Werewolf Therapeutics to create an animation about their INDUKINE molecules and how the molecules could transform immunotherapy as it is practiced today. Werewolf leadership had worked with XVIVO on a previous animation and really enjoyed the process and the final product. So it was an easy decision to pick a scientific animation studio when Werewolf needed help visualizing their science.
The Role Of PKR Activation In Sickle Cell Disease MOA Animation
XVIVO and Forma partnered together for multiple medical animation projects to educate both healthcare professionals and patients on their scientific approach. Sickle cell disease is an inherited genetic disease that has serious impacts on the people living with it. Forma Therapeutics is fiercely dedicated to improving the lives of these patients.